MYC on the path to cancer

Cell

Volumn 149, Issue 1, 2012, Pages 22-35

  Dang, Chi V ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMINE; MAX PROTEIN; MESSENGER RNA; MICRORNA; MYC PROTEIN;

BIOACCUMULATION; BIOENERGY; BIOMASS; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; DIMERIZATION; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; IN VIVO STUDY; ONCOGENE MYC; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 84859171807     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2012.03.003     Document Type: Review

References (229)

1. J.M. Adams, A.W. Harris, C.A. Pinkert, L.M. Corcoran, W.S. Alexander, S. Cory, R.D. Palmiter, and R.L. Brinster The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature 318 1985 533 538 (Pubitemid 16173038)
2. S. Adhikary, F. Marinoni, A. Hock, E. Hulleman, N. Popov, R. Beier, S. Bernard, M. Quarto, M. Capra, and S. Goettig The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation Cell 123 2005 409 421 (Pubitemid 41546672)
3. B.D. Aguda, Y. Kim, M.G. Piper-Hunter, A. Friedman, and C.B. Marsh MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc Proc. Natl. Acad. Sci. USA 105 2008 19678 19683
4. N. Ahmadiyeh, M.M. Pomerantz, C. Grisanzio, P. Herman, L. Jia, V. Almendro, H.H. He, M. Brown, X.S. Liu, and M. Davis 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC Proc. Natl. Acad. Sci. USA 107 2010 9742 9746
5. K. Akagi, T. Suzuki, R.M. Stephens, N.A. Jenkins, and N.G. Copeland RTCGD: retroviral tagged cancer gene database Nucleic Acids Res. 32 Database issue 2004 D523 D527
6. B. Amati, S. Dalton, M.W. Brooks, T.D. Littlewood, G.I. Evan, and H. Land Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max Nature 359 1992 423 426
7. B. Amati, M.W. Brooks, N. Levy, T.D. Littlewood, G.I. Evan, and H. Land Oncogenic activity of the c-Myc protein requires dimerization with Max Cell 72 1993 233 245 (Pubitemid 23044938)
8. H.A. Armelin, M.C. Armelin, K. Kelly, T. Stewart, P. Leder, B.H. Cochran, and C.D. Stiles Functional role for c-myc in mitogenic response to platelet-derived growth factor Nature 310 1984 655 660 (Pubitemid 14054330)
9. C. Arvanitis, and D.W. Felsher Conditional transgenic models define how MYC initiates and maintains tumorigenesis Semin. Cancer Biol. 16 2006 313 317 (Pubitemid 44311038)
10. G. Asher, and U. Schibler Crosstalk between components of circadian and metabolic cycles in mammals Cell Metab. 13 2011 125 137
11. E. Baena, A. Gandarillas, M. Vallespinós, J. Zanet, O. Bachs, C. Redondo, I. Fabregat, C. Martinez-A, and I.M. de Alborán c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver Proc. Natl. Acad. Sci. USA 102 2005 7286 7291 (Pubitemid 40696371)
12. M. Barna, A. Pusic, O. Zollo, M. Costa, N. Kondrashov, E. Rego, P.H. Rao, and D. Ruggero Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency Nature 456 2008 971 975
13. T.A. Baudino, C. McKay, H. Pendeville-Samain, J.A. Nilsson, K.H. Maclean, E.L. White, A.C. Davis, J.N. Ihle, and J.L. Cleveland c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression Genes Dev. 16 2002 2530 2543
14. S. Beer, A. Zetterberg, R.A. Ihrie, R.A. McTaggart, Q. Yang, N. Bradon, C. Arvanitis, L.D. Attardi, S. Feng, and B. Ruebner Developmental context determines latency of MYC-induced tumorigenesis PLoS Biol. 2 2004 e332
15. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, and M. Urashima The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
16. E.M. Blackwood, and R.N. Eisenman Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 251 1991 1211 1217 (Pubitemid 21926213)
17. E.M. Blackwood, T.G. Lugo, L. Kretzner, M.W. King, A.J. Street, O.N. Witte, and R.N. Eisenman Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein Mol. Biol. Cell 5 1994 597 609 (Pubitemid 24183448)
18. R.B. Boxer, J.W. Jang, L. Sintasath, and L.A. Chodosh Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation Cancer Cell 6 2004 577 586 (Pubitemid 40017701)
19. G.M. Brodeur, R.C. Seeger, M. Schwab, H.E. Varmus, and J.M. Bishop Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 224 1984 1121 1124 (Pubitemid 14106392)
20. T.A. Brooks, and L.H. Hurley Targeting MYC Expression through G-Quadruplexes Genes Cancer 1 2010 641 649
21. R.V. Brown, F.L. Danford, V. Gokhale, L.H. Hurley, and T.A. Brooks Demonstration that drug-targeted downregulation of MYC in non-hodgkins lymphoma is directly mediated through the promoter G-quadruplex J. Biol. Chem. 286 2011 41018 41027
22. I.G. Cannell, Y.W. Kong, S.J. Johnston, M.L. Chen, H.M. Collins, H.C. Dobbyn, A. Elia, T.R. Kress, M. Dickens, and M.J. Clemens p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication Proc. Natl. Acad. Sci. USA 107 2010 5375 5380
23. D. Cappellen, T. Schlange, M. Bauer, F. Maurer, and N.E. Hynes Novel c-MYC target genes mediate differential effects on cell proliferation and migration EMBO Rep. 8 2007 70 76 (Pubitemid 46043803)
24. S. Cawley, S. Bekiranov, H.H. Ng, P. Kapranov, E.A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, and A.J. Williams Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs Cell 116 2004 499 509 (Pubitemid 38264428)
25. K.B. Challagundla, X.X. Sun, X. Zhang, T. DeVine, Q. Zhang, R.C. Sears, and M.S. Dai Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress Mol. Cell. Biol. 31 2011 4007 4021
26. J.C. Chan, K.M. Hannan, K. Riddell, P.Y. Ng, A. Peck, R.S. Lee, S. Hung, M.V. Astle, M. Bywater, and M. Wall AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer Sci. Signal. 4 2011 ra56
27. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, K.M. West, C.V. Dang, A. Thomas-Tikhonenko, and J.T. Mendell Widespread microRNA repression by Myc contributes to tumorigenesis Nat. Genet. 40 2008 43 50
28. T.C. Chang, L.R. Zeitels, H.W. Hwang, R.R. Chivukula, E.A. Wentzel, M. Dews, J. Jung, P. Gao, C.V. Dang, and M.A. Beer Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation Proc. Natl. Acad. Sci. USA 106 2009 3384 3389
29. M. Chesi, D.F. Robbiani, M. Sebag, W.J. Chng, M. Affer, R. Tiedemann, R. Valdez, S.E. Palmer, S.S. Haas, and A.K. Stewart AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies Cancer Cell 13 2008 167 180 (Pubitemid 351163163)
30. N.R. Christoffersen, R. Shalgi, L.B. Frankel, E. Leucci, M. Lees, M. Klausen, Y. Pilpel, F.C. Nielsen, M. Oren, and A.H. Lund p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC Cell Death Differ. 17 2010 236 245
31. D.M. Clausen, J. Guo, R.A. Parise, J.H. Beumer, M.J. Egorin, J.S. Lazo, E.V. Prochownik, and J.L. Eiseman In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization J. Pharmacol. Exp. Ther. 335 2010 715 727
32. M.D. Cole, and V.H. Cowling Transcription-independent functions of MYC: regulation of translation and DNA replication Nat. Rev. Mol. Cell Biol. 9 2008 810 815
33. M. Conacci-Sorrell, C. Ngouenet, and R.N. Eisenman Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation Cell 142 2010 480 493
34. V.H. Cowling, and M.D. Cole The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding Mol. Cell. Biol. 27 2007 2059 2073 (Pubitemid 46418464)
35. V.H. Cowling, S. Chandriani, M.L. Whitfield, and M.D. Cole A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest Mol. Cell. Biol. 26 2006 4226 4239 (Pubitemid 43788022)
36. C.M. D'Cruz, E.J. Gunther, R.B. Boxer, J.L. Hartman, L. Sintasath, S.E. Moody, J.D. Cox, S.I. Ha, G.K. Belka, and A. Golant c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations Nat. Med. 7 2001 235 239 (Pubitemid 32148492)
37. J. Dai, M. Carver, L.H. Hurley, and D. Yang Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design J. Am. Chem. Soc. 133 2011 17673 17680
38. R. Dalla-Favera, M. Bregni, J. Erikson, D. Patterson, R.C. Gallo, and C.M. Croce Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc. Natl. Acad. Sci. USA 79 1982 7824 7827 (Pubitemid 13182471)
39. C.V. Dang The interplay between MYC and HIF in the Warburg effect Ernst Schering Found Symp. Proc. 2007 35 53
40. C.V. Dang, and W.M. Lee Identification of the human c-myc protein nuclear translocation signal Mol. Cell. Biol. 8 1988 4048 4054
41. C.V. Dang, K.A. O'Donnell, K.I. Zeller, T. Nguyen, R.C. Osthus, and F. Li The c-Myc target gene network Semin. Cancer Biol. 16 2006 253 264 (Pubitemid 44311039)
42. C.V. Dang, J.W. Kim, P. Gao, and J. Yustein The interplay between MYC and HIF in cancer Nat. Rev. Cancer 8 2008 51 56
43. E.V. Dang, J. Barbi, H.Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, and H.R. Yen Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 Cell 146 2011 772 784
44. J.E. Delmore, G.C. Issa, M.E. Lemieux, P.B. Rahl, J. Shi, H.M. Jacobs, E. Kastritis, T. Gilpatrick, R.M. Paranal, and J. Qi BET bromodomain inhibition as a therapeutic strategy to target c-Myc Cell 146 2011 904 917
45. J. den Hollander, S. Rimpi, J.R. Doherty, M. Rudelius, A. Buck, A. Hoellein, M. Kremer, N. Graf, M. Scheerer, and M.A. Hall Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state Blood 116 2010 1498 1505
46. M. Dews, J.L. Fox, S. Hultine, P. Sundaram, W. Wang, Y.Y. Liu, E. Furth, G.H. Enders, W. El-Deiry, and J.M. Schelter The myc-miR-17∼92 axis blunts TGFbeta signaling and production of multiple TGFbeta-dependent antiangiogenic factors Cancer Res. 70 2010 8233 8246
47. D. Dominguez-Sola, C.Y. Ying, C. Grandori, L. Ruggiero, B. Chen, M. Li, D.A. Galloway, W. Gu, J. Gautier, and R. Dalla-Favera Non-transcriptional control of DNA replication by c-Myc Nature 448 2007 445 451 (Pubitemid 47123512)
48. P.H. Duesberg, and P.K. Vogt Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes Proc. Natl. Acad. Sci. USA 76 1979 1633 1637 (Pubitemid 9175372)
49. R.A. Egler, E. Fernandes, K. Rothermund, S. Sereika, N. de Souza-Pinto, P. Jaruga, M. Dizdaroglu, and E.V. Prochownik Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1 Oncogene 24 2005 8038 8050 (Pubitemid 41746747)
50. C.M. Eischen, J.D. Weber, M.F. Roussel, C.J. Sherr, and J.L. Cleveland Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis Genes Dev. 13 1999 2658 2669 (Pubitemid 29508553)
51. K. Ellwood-Yen, T.G. Graeber, J. Wongvipat, M.L. Iruela-Arispe, J. Zhang, R. Matusik, G.V. Thomas, and C.L. Sawyers Myc-driven murine prostate cancer shares molecular features with human prostate tumors Cancer Cell 4 2003 223 238 (Pubitemid 37163836)
52. V.R. Fantin, J. St-Pierre, and P. Leder Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance Cancer Cell 9 2006 425 434 (Pubitemid 43832190)
53. D.W. Felsher MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms Genes Cancer 1 2010 597 604
54. D.W. Felsher, and J.M. Bishop Reversible tumorigenesis by MYC in hematopoietic lineages Mol. Cell 4 1999 199 207 (Pubitemid 29456888)
55. D.W. Felsher, and J.M. Bishop Transient excess of MYC activity can elicit genomic instability and tumorigenesis Proc. Natl. Acad. Sci. USA 96 1999 3940 3944 (Pubitemid 29169015)
56. Z.A. Felton-Edkins, N.S. Kenneth, T.R. Brown, N.L. Daly, N. Gomez-Roman, C. Grandori, R.N. Eisenman, and R.J. White Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc Cell Cycle 2 2003 181 184
57. P.C. Fernandez, S.R. Frank, L. Wang, M. Schroeder, S. Liu, J. Greene, A. Cocito, and B. Amati Genomic targets of the human c-Myc protein Genes Dev. 17 2003 1115 1129 (Pubitemid 36534986)
58. M. Fladvad, K. Zhou, A. Moshref, S. Pursglove, P. Säfsten, and M. Sunnerhagen N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding J. Mol. Biol. 346 2005 175 189 (Pubitemid 40128314)
59. A.V. Follis, D.I. Hammoudeh, H. Wang, E.V. Prochownik, and S.J. Metallo Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules Chem. Biol. 15 2008 1149 1155
60. A.V. Follis, D.I. Hammoudeh, A.T. Daab, and S.J. Metallo Small-molecule perturbation of competing interactions between c-Myc and Max Bioorg. Med. Chem. Lett. 19 2009 807 810
61. A. Frenzel, J. Lovén, and M.A. Henriksson Targeting MYC-regulated miRNAs to combat cancer Genes Cancer 1 2010 660 667
62. M. Frye, C. Gardner, E.R. Li, I. Arnold, and F.M. Watt Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment Development 130 2003 2793 2808 (Pubitemid 37069593)
63. A. Gandarillas, and F.M. Watt c-Myc promotes differentiation of human epidermal stem cells Genes Dev. 11 1997 2869 2882 (Pubitemid 27481687)
64. P. Gao, H. Zhang, R. Dinavahi, F. Li, Y. Xiang, V. Raman, Z.M. Bhujwalla, D.W. Felsher, L. Cheng, and J. Pevsner HIF-dependent antitumorigenic effect of antioxidants in vivo Cancer Cell 12 2007 230 238 (Pubitemid 47333417)
65. P. Gao, I. Tchernyshyov, T.C. Chang, Y.S. Lee, K. Kita, T. Ochi, K.I. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, and C.V. Dang c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
66. S. Giuriato, S. Ryeom, A.C. Fan, P. Bachireddy, R.C. Lynch, M.J. Rioth, J. van Riggelen, A.M. Kopelman, E. Passegué, and F. Tang Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch Proc. Natl. Acad. Sci. USA 103 2006 16266 16271 (Pubitemid 44715185)
67. N. Gomez-Roman, C. Grandori, R.N. Eisenman, and R.J. White Direct activation of RNA polymerase III transcription by c-Myc Nature 421 2003 290 294 (Pubitemid 36139136)
68. J.D. Gordan, J.A. Bertout, C.J. Hu, J.A. Diehl, and M.C. Simon HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity Cancer Cell 11 2007 335 347 (Pubitemid 46518312)
69. J.D. Gordan, P. Lal, V.R. Dondeti, R. Letrero, K.N. Parekh, C.E. Oquendo, R.A. Greenberg, K.T. Flaherty, W.K. Rathmell, and B. Keith HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma Cancer Cell 14 2008 435 446
70. C. Grandori, N. Gomez-Roman, Z.A. Felton-Edkins, C. Ngouenet, D.A. Galloway, R.N. Eisenman, and R.J. White c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I Nat. Cell Biol. 7 2005 311 318 (Pubitemid 40331133)
71. J.A. Graves, M. Metukuri, D. Scott, K. Rothermund, and E.V. Prochownik Regulation of reactive oxygen species homeostasis by peroxiredoxins and c-Myc J. Biol. Chem. 284 2009 6520 6529
72. P.J. Greasley, C. Bonnard, and B. Amati Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis Nucleic Acids Res. 28 2000 446 453 (Pubitemid 30057983)
73. M.A. Gregory, and S.R. Hann c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells Mol. Cell. Biol. 20 2000 2423 2435 (Pubitemid 30152050)
74. M.A. Gregory, Y. Qi, and S.R. Hann Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization J. Biol. Chem. 278 2003 51606 51612 (Pubitemid 38020405)
75. A.V. Grinberg, C.D. Hu, and T.K. Kerppola Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells Mol. Cell. Biol. 24 2004 4294 4308 (Pubitemid 41071000)
76. I. Guney, S. Wu, and J.M. Sedivy Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a) Proc. Natl. Acad. Sci. USA 103 2006 3645 3650 (Pubitemid 43376609)
77. B. Gurel, T. Iwata, C.M. Koh, R.B. Jenkins, F. Lan, C. Van Dang, J.L. Hicks, J. Morgan, T.C. Cornish, and S. Sutcliffe Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis Mod. Pathol. 21 2008 1156 1167
78. T. Habib, H. Park, M. Tsang, I.M. de Alborán, A. Nicks, L. Wilson, P.S. Knoepfler, S. Andrews, D.J. Rawlings, R.N. Eisenman, and B.M. Iritani Myc stimulates B lymphocyte differentiation and amplifies calcium signaling J. Cell Biol. 179 2007 717 731 (Pubitemid 350146257)
79. D.I. Hammoudeh, A.V. Follis, E.V. Prochownik, and S.J. Metallo Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc J. Am. Chem. Soc. 131 2009 7390 7401
80. S.R. Hann, K. Sloan-Brown, and G.D. Spotts Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation Genes Dev. 6 1992 1229 1240
81. L. He, J. Liu, I. Collins, S. Sanford, B. O'Connell, C.J. Benham, and D. Levens Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression EMBO J. 19 2000 1034 1044 (Pubitemid 30119828)
82. T.C. He, A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein, and K.W. Kinzler Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512 (Pubitemid 28425575)
83. H. Hermeking, C. Rago, M. Schuhmacher, Q. Li, J.F. Barrett, A.J. Obaya, B.C. O'Connell, M.K. Mateyak, W. Tam, and F. Kohlhuber Identification of CDK4 as a target of c-MYC Proc. Natl. Acad. Sci. USA 97 2000 2229 2234 (Pubitemid 30134051)
84. R.W. Holley, and J.A. Kiernan Control of the initiation of DNA synthesis in 3T3 cells: low-molecular weight nutrients Proc. Natl. Acad. Sci. USA 71 1974 2942 2945
85. R. Hopewell, and E.B. Ziff The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max Mol. Cell. Biol. 15 1995 3470 3478
86. J. Hu, A. Banerjee, and D.J. Goss Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: importance of protein-protein and protein-DNA interactions Biochemistry 44 2005 11855 11863 (Pubitemid 41262720)
87. S.S. Hu, M.M. Lai, and P.K. Vogt Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping Proc. Natl. Acad. Sci. USA 76 1979 1265 1268 (Pubitemid 9143720)
88. M.J. Huang, Y.C. Cheng, C.R. Liu, S. Lin, and H.E. Liu A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia Exp. Hematol. 34 2006 1480 1489 (Pubitemid 44548118)
89. L.H. Hurley, D.D. Von Hoff, A. Siddiqui-Jain, and D. Yang Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element Semin. Oncol. 33 2006 498 512 (Pubitemid 44142743)
90. N. Ilic, T. Utermark, H.R. Widlund, and T.M. Roberts PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis Proc. Natl. Acad. Sci. USA 108 2011 E699 E708
91. B.M. Iritani, J. Delrow, C. Grandori, I. Gomez, M. Klacking, L.S. Carlos, and R.N. Eisenman Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1 EMBO J. 21 2002 4820 4830
92. M. Jain, C. Arvanitis, K. Chu, W. Dewey, E. Leonhardt, M. Trinh, C.D. Sundberg, J.M. Bishop, and D.W. Felsher Sustained loss of a neoplastic phenotype by brief inactivation of MYC Science 297 2002 102 104 (Pubitemid 34743102)
93. H. Ji, G. Wu, X. Zhan, A. Nolan, C. Koh, A. De Marzo, H.M. Doan, J. Fan, C. Cheadle, and M. Fallahi Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation PLoS ONE 6 2011 e26057
94. L.A. Johnston, D.A. Prober, B.A. Edgar, R.N. Eisenman, and P. Gallant Drosophila myc regulates cellular growth during development Cell 98 1999 779 790 (Pubitemid 29446895)
95. J. Jonkers, and A. Berns Oncogene addiction: sometimes a temporary slavery Cancer Cell 6 2004 535 538 (Pubitemid 40017696)
96. A. Karlsson, D. Deb-Basu, A. Cherry, S. Turner, J. Ford, and D.W. Felsher Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression Proc. Natl. Acad. Sci. USA 100 2003 9974 9979 (Pubitemid 37087053)
97. G.J. Kato, J. Barrett, M. Villa-Garcia, and C.V. Dang An amino-terminal c-myc domain required for neoplastic transformation activates transcription Mol. Cell. Biol. 10 1990 5914 5920
98. G.J. Kato, W.M. Lee, L.L. Chen, and C.V. Dang Max: functional domains and interaction with c-Myc Genes Dev. 6 1992 81 92
99. K. Kelly, B.H. Cochran, C.D. Stiles, and P. Leder Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor Cell 35 1983 603 610 (Pubitemid 14168364)
100. N.S. Kenneth, B.A. Ramsbottom, N. Gomez-Roman, L. Marshall, P.A. Cole, and R.J. White TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription Proc. Natl. Acad. Sci. USA 104 2007 14917 14922 (Pubitemid 47619568)
101. J.D. Kessler, K.T. Kahle, T. Sun, K.L. Meerbrey, M.R. Schlabach, E.M. Schmitt, S.O. Skinner, Q. Xu, M.Z. Li, and Z.C. Hartman A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis Science 335 2012 348 353
102. H.H. Kim, Y. Kuwano, S. Srikantan, E.K. Lee, J.L. Martindale, and M. Gorospe HuR recruits let-7/RISC to repress c-Myc expression Genes Dev. 23 2009 1743 1748
103. J. Kim, A.J. Woo, J. Chu, J.W. Snow, Y. Fujiwara, C.G. Kim, A.B. Cantor, and S.H. Orkin A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs Cell 143 2010 313 324
104. J.W. Kim, P. Gao, Y.C. Liu, G.L. Semenza, and C.V. Dang Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 Mol. Cell. Biol. 27 2007 7381 7393 (Pubitemid 350033646)
105. S. Kim, Q. Li, C.V. Dang, and L.A. Lee Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo Proc. Natl. Acad. Sci. USA 97 2000 11198 11202
106. U.E. Knies-Bamforth, S.B. Fox, R. Poulsom, G.I. Evan, and A.L. Harris c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism Cancer Res. 64 2004 6563 6570 (Pubitemid 39297915)
107. N.E. Kohl, C.E. Gee, and F.W. Alt Activated expression of the N-myc gene in human neuroblastomas and related tumors Science 226 1984 1335 1337 (Pubitemid 15215589)
108. C.M. Koh, B. Gurel, S. Sutcliffe, M.J. Aryee, D. Schultz, T. Iwata, M. Uemura, K.I. Zeller, U. Anele, and Q. Zheng Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene Am. J. Pathol. 178 2011 1824 1834
109. C.M. Koh, T. Iwata, Q. Zheng, C. Bethel, S. Yegnasubramanian, and A.M. De Marzo Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms Oncotarget 2 2011 669 683
110. J. Kota, R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, H.W. Hwang, T.C. Chang, P. Vivekanandan, M. Torbenson, and K.R. Clark Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 2009 1005 1017
111. T.R. Kress, I.G. Cannell, A.B. Brenkman, B. Samans, M. Gaestel, P. Roepman, B.M. Burgering, M. Bushell, A. Rosenwald, and M. Eilers The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis Mol. Cell 41 2011 445 457
112. L. Kretzner, E.M. Blackwood, and R.N. Eisenman Myc and Max proteins possess distinct transcriptional activities Nature 359 1992 426 429
113. J.R. Krycer, L.J. Sharpe, W. Luu, and A.J. Brown The Akt-SREBP nexus: cell signaling meets lipid metabolism Trends Endocrinol. Metab. 21 2010 268 276
114. H. Land, L.F. Parada, and R.A. Weinberg Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes Nature 304 1983 596 602 (Pubitemid 13035496)
115. E. Laurenti, B. Varnum-Finney, A. Wilson, I. Ferrero, W.E. Blanco-Bose, A. Ehninger, P.S. Knoepfler, P.F. Cheng, H.R. MacDonald, and R.N. Eisenman Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity Cell Stem Cell 3 2008 611 624
116. E. Laurenti, A. Wilson, and A. Trumpp Myc's other life: stem cells and beyond Curr. Opin. Cell Biol. 21 2009 844 854
117. A. Le, C.R. Cooper, A.M. Gouw, R. Dinavahi, A. Maitra, L.M. Deck, R.E. Royer, D.L. Vander Jagt, G.L. Semenza, and C.V. Dang Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Proc. Natl. Acad. Sci. USA 107 2010 2037 2042
118. A. Le, A.N. Lane, M. Hamaker, S. Bose, A. Gouw, J. Barbi, T. Tsukamoto, C.J. Rojas, B.S. Slusher, and H. Zhang Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells Cell Metab. 15 2012 110 121
119. A. Leder, P.K. Pattengale, A. Kuo, T.A. Stewart, and P. Leder Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development Cell 45 1986 485 495 (Pubitemid 16014971)
120. D. Levens You don't muck with MYC Genes Cancer 1 2010 547 554
121. F. Li, Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, K.A. O'Donnell, J.W. Kim, J.T. Yustein, L.A. Lee, and C.V. Dang Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis Mol. Cell. Biol. 25 2005 6225 6234 (Pubitemid 40946570)
122. F. Li, Y. Xiang, J. Potter, R. Dinavahi, C.V. Dang, and L.A. Lee Conditional deletion of c-myc does not impair liver regeneration Cancer Res. 66 2006 5608 5612 (Pubitemid 43927111)
123. Q. Li, and C.V. Dang c-Myc overexpression uncouples DNA replication from mitosis Mol. Cell. Biol. 19 1999 5339 5351 (Pubitemid 29339893)
124. Z. Li, S. Van Calcar, C. Qu, W.K. Cavenee, M.Q. Zhang, and B. Ren A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells Proc. Natl. Acad. Sci. USA 100 2003 8164 8169 (Pubitemid 36842516)
125. Z. Li, D. Boone, and S.R. Hann Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation Proc. Natl. Acad. Sci. USA 105 2008 18794 18799
126. X. Liu, J. Tesfai, Y.A. Evrard, S.Y. Dent, and E. Martinez c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation J. Biol. Chem. 278 2003 20405 20412 (Pubitemid 36799242)
127. S.F. Louis, B.J. Vermolen, Y. Garini, I.T. Young, A. Guffei, Z. Lichtensztejn, F. Kuttler, T.C. Chuang, S. Moshir, and V. Mougey c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus Proc. Natl. Acad. Sci. USA 102 2005 9613 9618 (Pubitemid 40981729)
128. J. Lovén, N. Zinin, T. Wahlström, I. Müller, P. Brodin, E. Fredlund, U. Ribacke, A. Pivarcsi, S. Phlman, and M. Henriksson MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma Proc. Natl. Acad. Sci. USA 107 2010 1553 1558
129. L. Ma, J. Young, H. Prabhala, E. Pan, P. Mestdagh, D. Muth, J. Teruya-Feldstein, F. Reinhardt, T.T. Onder, and S. Valastyan miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat. Cell Biol. 12 2010 247 256
130. B.A. Malynn, I.M. de Alboran, R.C. O'Hagan, R. Bronson, L. Davidson, R.A. DePinho, and F.W. Alt N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation Genes Dev. 14 2000 1390 1399 (Pubitemid 30397082)
131. J.M. Maris Recent advances in neuroblastoma N. Engl. J. Med. 362 2010 2202 2211
132. I.J. McEwan, K. Dahlman-Wright, J. Ford, and A.P. Wright Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding Biochemistry 35 1996 9584 9593 (Pubitemid 26320067)
133. S.B. McMahon, M.A. Wood, and M.D. Cole The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc Mol. Cell. Biol. 20 2000 556 562 (Pubitemid 30023097)
134. A. Menssen, A. Epanchintsev, D. Lodygin, N. Rezaei, P. Jung, B. Verdoodt, J. Diebold, and H. Hermeking c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability Cell Cycle 6 2007 339 352
135. A. Menssen, P. Hydbring, K. Kapelle, J. Vervoorts, J. Diebold, B. Luscher, L.G. Larsson, and H. Hermeking The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop Proc. Natl. Acad. Sci. USA 109 2012 E187 E196
136. J.A. Mertz, A.R. Conery, B.M. Bryant, P. Sandy, S. Balasubramanian, D.A. Mele, L. Bergeron, and R.J. Sims 3rd Targeting MYC dependence in cancer by inhibiting BET bromodomains Proc. Natl. Acad. Sci. USA 108 2011 16669 16674
137. P. Mestdagh, A.K. Boström, F. Impens, E. Fredlund, G. Van Peer, P. De Antonellis, K. von Stedingk, B. Ghesquire, S. Schulte, and M. Dews The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma Mol. Cell 40 2010 762 773
138. M.K. Muellner, I.Z. Uras, B.V. Gapp, C. Kerzendorfer, M. Smida, H. Lechtermann, N. Craig-Mueller, J. Colinge, G. Duernberger, and S.M. Nijman A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer Nat. Chem. Biol. 7 2011 787 793
139. M. Murga, S. Campaner, A.J. Lopez-Contreras, L.I. Toledo, R. Soria, M.F. Montaña, L. D'Artista, T. Schleker, C. Guerra, and E. Garcia Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors Nat. Struct. Mol. Biol. 18 2011 1331 1335
140. D.J. Murphy, M.R. Junttila, L. Pouyet, A. Karnezis, K. Shchors, D.A. Bui, L. Brown-Swigart, L. Johnson, and G.I. Evan Distinct thresholds govern Myc's biological output in vivo Cancer Cell 14 2008 447 457
141. G. Mustata, A.V. Follis, D.I. Hammoudeh, S.J. Metallo, H. Wang, E.V. Prochownik, J.S. Lazo, and I. Bahar Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model J. Med. Chem. 52 2009 1247 1250
142. S.K. Nair, and S.K. Burley X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors Cell 112 2003 193 205 (Pubitemid 36144109)
143. M.M. Nau, B.J. Brooks, J. Battey, E. Sausville, A.F. Gazdar, I.R. Kirsch, O.W. McBride, V. Bertness, G.F. Hollis, and J.D. Minna L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer Nature 318 1985 69 73 (Pubitemid 16230338)
144. P.E. Neiman, R. Kimmel, A. Icreverzi, K. Elsaesser, S.J. Bowers, J. Burnside, and J. Delrow Genomic instability during Myc-induced lymphomagenesis in the bursa of Fabricius Oncogene 25 2006 6325 6335 (Pubitemid 44564748)
145. M.A. Nikiforov, S. Chandriani, J. Park, I. Kotenko, D. Matheos, A. Johnsson, S.B. McMahon, and M.D. Cole TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins Mol. Cell. Biol. 22 2002 5054 5063 (Pubitemid 34700697)
146. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843 (Pubitemid 40839736)
147. H. Okuyama, H. Endo, T. Akashika, K. Kato, and M. Inoue Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose Cancer Res. 70 2010 10213 10223
148. A. Orian, B. van Steensel, J. Delrow, H.J. Bussemaker, L. Li, T. Sawado,
149. A. Orian, S.S. Grewal, P.S. Knoepfler, B.A. Edgar, S.M. Parkhurst, and R.N. Eisenman Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors Cold Spring Harb. Symp. Quant. Biol. 70 2005 299 307 (Pubitemid 44124884)
150. R.C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L.A. Lee, and C.V. Dang Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc J. Biol. Chem. 275 2000 21797 21800 (Pubitemid 30621745)
151. N. Palaskas, S.M. Larson, N. Schultz, E. Komisopoulou, J. Wong, D. Rohle, C. Campos, N. Yannuzzi, J.R. Osborne, and I. Linkov 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers Cancer Res. 71 2011 5164 5174
152. T. Palomero, W.K. Lim, D.T. Odom, M.L. Sulis, P.J. Real, A. Margolin, K.C. Barnes, J. O'Neil, D. Neuberg, and A.P. Weng NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth Proc. Natl. Acad. Sci. USA 103 2006 18261 18266 (Pubitemid 44871646)
153. S. Park, S. Chung, K.M. Kim, K.C. Jung, C. Park, E.R. Hahm, and C.H. Yang Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding Biochim. Biophys. Acta 1670 2004 217 228 (Pubitemid 38229772)
154. S. Pelengaris, T. Littlewood, M. Khan, G. Elia, and G. Evan Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion Mol. Cell 3 1999 565 577 (Pubitemid 29268440)
155. D. Perna, G. Faga, A. Verrecchia, M.M. Gorski, I. Barozzi, V. Narang, J. Khng, K.C. Lim, W.K. Sung, and R. Sanges Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts Oncogene 2011 10.1038/onc.2011.359 Published online August 22 2011
156. M.T. Pickering, B.M. Stadler, and T.F. Kowalik miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression Oncogene 28 2009 140 145
157. A. Pineda-Lucena, and C.H. Arrowsmith 1H, 13C and 15N resonance assignments and secondary structure of the c-Myc binding domain (MBD) and the SH3 domain of the tumor suppressor Bin1 J. Biomol. NMR 19 2001 191 192 (Pubitemid 32184447)
158. M.M. Pomerantz, N. Ahmadiyeh, L. Jia, P. Herman, M.P. Verzi, H. Doddapaneni, C.A. Beckwith, J.A. Chan, A. Hills, and M. Davis The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer Nat. Genet. 41 2009 882 884
159. N. Popov, M. Wanzel, M. Madiredjo, D. Zhang, R. Beijersbergen, R. Bernards, R. Moll, S.J. Elledge, and M. Eilers The ubiquitin-specific protease USP28 is required for MYC stability Nat. Cell Biol. 9 2007 765 774 (Pubitemid 47019463)
160. N. Popov, C. Schülein, L.A. Jaenicke, and M. Eilers Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover Nat. Cell Biol. 12 2010 973 981
161. E.V. Prochownik c-Myc: linking transformation and genomic instability Curr. Mol. Med. 8 2008 446 458
162. E.V. Prochownik, and P.K. Vogt Therapeutic targeting of Myc Genes Cancer 1 2010 650 659
163. G. Qing, N. Skuli, P.A. Mayes, B. Pawel, D. Martinez, J.M. Maris, and M.C. Simon Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha Cancer Res. 70 2010 10351 10361
164. P.B. Rahl, C.Y. Lin, A.C. Seila, R.A. Flynn, S. McCuine, C.B. Burge, P.A. Sharp, and R.A. Young c-Myc regulates transcriptional pause release Cell 141 2010 432 445
165. K. Rakhra, P. Bachireddy, T. Zabuawala, R. Zeiser, L. Xu, A. Kopelman, A.C. Fan, Q. Yang, L. Braunstein, and E. Crosby CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation Cancer Cell 18 2010 485 498
166. K.M. Ramsey, J. Yoshino, C.S. Brace, D. Abrassart, Y. Kobayashi, B. Marcheva, H.K. Hong, J.L. Chong, E.D. Buhr, and C. Lee Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis Science 324 2009 651 654
167. S. Ray, K.R. Atkuri, D. Deb-Basu, A.S. Adler, H.Y. Chang, L.A. Herzenberg, and D.W. Felsher MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species Cancer Res. 66 2006 6598 6605 (Pubitemid 44085615)
168. M. Sachdeva, S. Zhu, F. Wu, H. Wu, V. Walia, S. Kumar, R. Elble, K. Watabe, and Y.Y. Mo p53 represses c-Myc through induction of the tumor suppressor miR-145 Proc. Natl. Acad. Sci. USA 106 2009 3207 3212
169. S.E. Salghetti, S.Y. Kim, and W.P. Tansey Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc EMBO J. 18 1999 717 726 (Pubitemid 29057256)
170. S. Sander, L. Bullinger, K. Klapproth, K. Fiedler, H.A. Kestler, T.F. Barth, P. Möller, S. Stilgenbauer, J.R. Pollack, and T. Wirth MYC stimulates EZH2 expression by repression of its negative regulator miR-26a Blood 112 2008 4202 4212
171. O.J. Sansom, V.S. Meniel, V. Muncan, T.J. Phesse, J.A. Wilkins, K.R. Reed, J.K. Vass, D. Athineos, H. Clevers, and A.R. Clarke Myc deletion rescues Apc deficiency in the small intestine Nature 446 2007 676 679 (Pubitemid 46606884)
172. S. Sauvé, J.F. Naud, and P. Lavigne The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors J. Mol. Biol. 365 2007 1163 1175 (Pubitemid 46014181)
173. R.C. Scarpulla Transcriptional paradigms in mammalian mitochondrial biogenesis and function Physiol. Rev. 88 2008 611 638 (Pubitemid 351520089)
174. I. Schlosser, M. Hölzel, M. Mürnseer, H. Burtscher, U.H. Weidle, and D. Eick A role for c-Myc in the regulation of ribosomal RNA processing Nucleic Acids Res. 31 2003 6148 6156 (Pubitemid 37442342)
175. I. Schlosser, M. Hölzel, R. Hoffmann, H. Burtscher, F. Kohlhuber, M. Schuhmacher, R. Chapman, U.H. Weidle, and D. Eick Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line Oncogene 24 2005 520 524 (Pubitemid 40188599)
176. A. Schneider, K. Peukert, M. Eilers, and F. Hänel Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc Curr. Top. Microbiol. Immunol. 224 1997 137 146 (Pubitemid 27368550)
177. M.J. Seltzer, B.D. Bennett, A.D. Joshi, P. Gao, A.G. Thomas, D.V. Ferraris, T. Tsukamoto, C.J. Rojas, B.S. Slusher, and J.D. Rabinowitz Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1 Cancer Res. 70 2010 8981 8987
178. G.L. Semenza Hypoxia-inducible factor 1 (HIF-1) pathway Sci. STKE 2007 2007 cm8
179. J. Seoane, C. Pouponnot, P. Staller, M. Schader, M. Eilers, and J. Massagué TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b Nat. Cell Biol. 3 2001 400 408 (Pubitemid 32288448)
180. P. Seth, A. Grant, J. Tang, E. Vinogradov, X. Wang, R. Lenkinski, and V.P. Sukhatme On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate Neoplasia 13 2011 60 71
181. C.M. Shachaf, A.M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, S. Mandl, M.H. Bachmann, A.D. Borowsky, B. Ruebner, and R.D. Cardiff MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Nature 431 2004 1112 1117 (Pubitemid 39472236)
182. C.M. Shachaf, A.J. Gentles, S. Elchuri, D. Sahoo, Y. Soen, O. Sharpe, O.D. Perez, M. Chang, D. Mitchel, and W.H. Robinson Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance Cancer Res. 68 2008 5132 5142
183. V.M. Sharma, J.A. Calvo, K.M. Draheim, L.A. Cunningham, N. Hermance, L. Beverly, V. Krishnamoorthy, M. Bhasin, A.J. Capobianco, and M.A. Kelliher Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc Mol. Cell. Biol. 26 2006 8022 8031 (Pubitemid 44631001)
184. K. Shchors, E. Shchors, F. Rostker, E.R. Lawlor, L. Brown-Swigart, and G.I. Evan The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta Genes Dev. 20 2006 2527 2538 (Pubitemid 44396838)
185. D. Sheiness, and J.M. Bishop DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus J. Virol. 31 1979 514 521 (Pubitemid 9233898)
186. L.Z. Shi, R. Wang, G. Huang, P. Vogel, G. Neale, D.R. Green, and H. Chi HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells J. Exp. Med. 208 2011 1367 1376
187. H. Shim, C. Dolde, B.C. Lewis, C.S. Wu, G. Dang, R.A. Jungmann, R. Dalla-Favera, and C.V. Dang c-Myc transactivation of LDH-A: implications for tumor metabolism and growth Proc. Natl. Acad. Sci. USA 94 1997 6658 6663 (Pubitemid 27281920)
188. H. Shim, Y.S. Chun, B.C. Lewis, and C.V. Dang A unique glucose-dependent apoptotic pathway induced by c-Myc Proc. Natl. Acad. Sci. USA 95 1998 1511 1516 (Pubitemid 28103423)
189. Y. Shou, M.L. Martelli, A. Gabrea, Y. Qi, L.A. Brents, A. Roschke, G. Dewald, I.R. Kirsch, P.L. Bergsagel, and W.M. Kuehl Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma Proc. Natl. Acad. Sci. USA 97 2000 228 233 (Pubitemid 30055813)
190. A.M. Singh, and S. Dalton The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming Cell Stem Cell 5 2009 141 149
191. N.M. Sodir, L.B. Swigart, A.N. Karnezis, D. Hanahan, G.I. Evan, and L. Soucek Endogenous Myc maintains the tumor microenvironment Genes Dev. 25 2011 907 916
192. L.B. Song, J. Li, W.T. Liao, Y. Feng, C.P. Yu, L.J. Hu, Q.L. Kong, L.H. Xu, X. Zhang, and W.L. Liu The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells J. Clin. Invest. 119 2009 3626 3636
193. J. Sotelo, D. Esposito, M.A. Duhagon, K. Banfield, J. Mehalko, H. Liao, R.M. Stephens, T.J. Harris, D.J. Munroe, and X. Wu Long-range enhancers on 8q24 regulate c-Myc Proc. Natl. Acad. Sci. USA 107 2010 3001 3005
194. L. Soucek, J. Whitfield, C.P. Martins, A.J. Finch, D.J. Murphy, N.M. Sodir, A.N. Karnezis, L.B. Swigart, S. Nasi, and G.I. Evan Modelling Myc inhibition as a cancer therapy Nature 455 2008 679 683
195. G.D. Spotts, S.V. Patel, Q. Xiao, and S.R. Hann Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins Mol. Cell. Biol. 17 1997 1459 1468 (Pubitemid 27097375)
196. D. Steiger, M. Furrer, D. Schwinkendorf, and P. Gallant Max-independent functions of Myc in Drosophila melanogaster Nat. Genet. 40 2008 1084 1091
197. C.R. Stumpf, and D. Ruggero The cancerous translation apparatus Curr. Opin. Genet. Dev. 21 2011 474 483
198. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
199. R. Taub, I. Kirsch, C. Morton, G. Lenoir, D. Swan, S. Tronick, S. Aaronson, and P. Leder Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells Proc. Natl. Acad. Sci. USA 79 1982 7837 7841 (Pubitemid 13182474)
200. L.R. Thomas, and W.P. Tansey Proteolytic control of the oncoprotein transcription factor Myc Adv. Cancer Res. 110 2011 77 106
201. S. Tuupanen, M. Turunen, R. Lehtonen, O. Hallikas, S. Vanharanta, T. Kivioja, M. Björklund, G. Wei, J. Yan, and I. Niittymäki The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling Nat. Genet. 41 2009 885 890
202. O. Vafa, M. Wade, S. Kern, M. Beeche, T.K. Pandita, G.M. Hampton, and G.M. Wahl c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability Mol. Cell 9 2002 1031 1044 (Pubitemid 34626672)
203. J. van Riggelen, J. Müller, T. Otto, V. Beuger, A. Yetil, P.S. Choi, C. Kosan, T. Möröy, D.W. Felsher, and M. Eilers The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance Genes Dev. 24 2010 1281 1294
204. J. van Riggelen, A. Yetil, and D.W. Felsher MYC as a regulator of ribosome biogenesis and protein synthesis Nat. Rev. Cancer 10 2010 301 309
205. B. Vennstrom, D. Sheiness, J. Zabielski, and J.M. Bishop Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29 J. Virol. 42 1982 773 779 (Pubitemid 12125621)
206. H. Wang, S. Mannava, V. Grachtchouk, D. Zhuang, M.S. Soengas, A.V. Gudkov, E.V. Prochownik, and M.A. Nikiforov c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle Oncogene 27 2008 1905 1915 (Pubitemid 351430817)
207. J.B. Wang, J.W. Erickson, R. Fuji, S. Ramachandran, P. Gao, R. Dinavahi, K.F. Wilson, A.L. Ambrosio, S.M. Dias, C.V. Dang, and R.A. Cerione Targeting mitochondrial glutaminase activity inhibits oncogenic transformation Cancer Cell 18 2010 207 219
208. R. Wang, C.P. Dillon, L.Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L.L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D.R. Green The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation Immunity 35 2011 871 882
209. X. Wang, M. Cunningham, X. Zhang, S. Tokarz, B. Laraway, M. Troxell, and R.C. Sears Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland Cancer Res. 71 2011 925 936
210. M. Wanzel, A.C. Russ, D. Kleine-Kohlbrecher, E. Colombo, P.G. Pelicci, and M. Eilers A ribosomal protein L23-nucleophosmin circuit coordinates Miz1 function with cell growth Nat. Cell Biol. 10 2008 1051 1061
211. N.F. Wasserman, I. Aneas, and M.A. Nobrega An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer Genome Res. 20 2010 1191 1197
212. F.M. Watt, M. Frye, and S.A. Benitah MYC in mammalian epidermis: how can an oncogene stimulate differentiation? Nat. Rev. Cancer 8 2008 234 242 (Pubitemid 351301841)
213. A.P. Weng, J.M. Millholland, Y. Yashiro-Ohtani, M.L. Arcangeli, A. Lau, C. Wai, C. Del Bianco, C.G. Rodriguez, H. Sai, and J. Tobias c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma Genes Dev. 20 2006 2096 2109 (Pubitemid 44157460)
214. J.A. Wilkins, and O.J. Sansom C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine Cancer Res. 68 2008 4963 4966
215. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, and C.B. Thompson Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. USA 105 2008 18782 18787
216. D.J. Wong, H. Liu, T.W. Ridky, D. Cassarino, E. Segal, and H.Y. Chang Module map of stem cell genes guides creation of epithelial cancer stem cells Cell Stem Cell 2 2008 333 344 (Pubitemid 351455242)
217. D.R. Wonsey, K.I. Zeller, and C.V. Dang The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation Proc. Natl. Acad. Sci. USA 99 2002 6649 6654 (Pubitemid 34526187)
218. J.B. Wright, S.J. Brown, and M.D. Cole Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells Mol. Cell. Biol. 30 2010 1411 1420
219. C.H. Wu, J. van Riggelen, A. Yetil, A.C. Fan, P. Bachireddy, and D.W. Felsher Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation Proc. Natl. Acad. Sci. USA 104 2007 13028 13033 (Pubitemid 351737587)
220. Q. Xiao, G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S.R. Hann Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis Genes Dev. 12 1998 3803 3808 (Pubitemid 29024842)
221. X. Xie, J. Lu, E.J. Kulbokas, T.R. Golub, V. Mootha, K. Lindblad-Toh, E.S. Lander, and M. Kellis Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals Nature 434 2005 338 345 (Pubitemid 40469170)
222. H. Xie, V.A. Valera, M.J. Merino, A.M. Amato, S. Signoretti, W.M. Linehan, V.P. Sukhatme, and P. Seth LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer Mol. Cancer Ther. 8 2009 626 635
223. D. Yang, H. Liu, A. Goga, S. Kim, M. Yuneva, and J.M. Bishop Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase Proc. Natl. Acad. Sci. USA 107 2010 13836 13841
224. M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells J. Cell Biol. 178 2007 93 105 (Pubitemid 47026405)
225. J.T. Yustein, Y.C. Liu, P. Gao, C. Jie, A. Le, M. Vuica-Ross, W.J. Chng, C.G. Eberhart, P.L. Bergsagel, and C.V. Dang Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model Proc. Natl. Acad. Sci. USA 107 2010 3534 3539
226. K.I. Zeller, X. Zhao, C.W. Lee, K.P. Chiu, F. Yao, J.T. Yustein, H.S. Ooi, Y.L. Orlov, A. Shahab, and H.C. Yong Global mapping of c-Myc binding sites and target gene networks in human B cells Proc. Natl. Acad. Sci. USA 103 2006 17834 17839 (Pubitemid 44852246)
227. H. Zhang, P. Gao, R. Fukuda, G. Kumar, B. Krishnamachary, K.I. Zeller, C.V. Dang, and G.L. Semenza HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity Cancer Cell 11 2007 407 420 (Pubitemid 46670080)
228. D. Zhuang, S. Mannava, V. Grachtchouk, W.H. Tang, S. Patil, J.A. Wawrzyniak, A.E. Berman, T.J. Giordano, E.V. Prochownik, M.S. Soengas, and M.A. Nikiforov C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells Oncogene 27 2008 6623 6634
229. F. Zindy, C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.F. Roussel Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization Genes Dev. 12 1998 2424 2433 (Pubitemid 28371361)